Product
HR011408 injection
Aliases
HR011408 injection; NovoRapid®, HR011408 injection Placebo; HR011408 injection
2 clinical trials
1 indication
Indication
DiabetesClinical trial
A Single Center, Randomized, Double-Blind, 2-period, 2-sequence Crossover Designed Study to Evaluate the Pharmacokinetics and Pharmacodynamics Between HR011408 and NovoRapid® in Healthy SubjectStatus: Completed, Estimated PCD: 2023-10-26
Clinical trial
Comparing Pharmacokinetics and Pharmacodynamics Between HR011408 and NovoRapid® in Subjects With Diabetics- A Randomized, Double-Blind, Three-cycle Crossover Phase I Clinical TrialStatus: Not yet recruiting, Estimated PCD: 2024-07-01